In the News Archive
- 2016-05-11 - European Commission Approves The First And Only Immuno-Oncology Combination, Bristol-Myers Squibb's Opdivo® (nivolumab) + Yervoy® (ipilimumab) Regimen, For Treatment Of Advanced Melanoma
- 2016-05-09 - Research discovers mechanism that causes cancer cells to escape from the immune system
- 2016-05-05 - American Society of Hematology Presents Toolkit to Support Quality of Care in the Transition from Pediatric to Adult Practices
- 2016-05-05 - Protein may Predict Response to Immunotherapy in Patients with Metastatic Melanoma
- 2016-05-05 - Preliminary Results Comparing PD-L1 IHC Diagnostic Assays in Lung Cancer Released
- 2016-04-21 - Fighting Cancer With Killer T-Cells: 5 Developments To Watch
- 2014-10-09 - Halozyme Gets FDA Orphan Drug Status for PEGPH20 to Treat Pancreatic Cancer
- 2014-09-23 - As-needed rituximab controlled follicular lymphoma with less treatment
- 2014-09-23 - Cyclacel's CYC065 CDK Inhibitor Shows Therapeutic Potential In Acute Leukemias
- 2014-09-23 - New prognostic ‘standard’ for follicular lymphoma
- 2014-09-17 - Rosenberg Sees New Milestone in Latest CAR Findings
- 2014-09-17 - FDA News Roundup: Astellas, Sanofi Pasteur, Orexigen, and More
- 2014-09-17 - Improved survival shown in early-stage Hodgkin's Disease patients who receive radiation therapy
- 2014-09-17 - Novel Drug Targeting Leukemia Cells Enters Clinical Trial
- 2014-08-25 - FDA grants fast track designation to AG-221 for IDH2-mutant AML